HTML from...
URL: https://open.canada.ca/data/en/dataset/15a5bf9a-b1e2-4e61-8515-e68598682b61
Health Canada carried out a safety review after learning that the European Medicines Agency was looking into a potential interaction between levetiracetam and methotrexate. The interaction between the two drugs may lead to higher amount of methotrexate in the blood, which may cause serious side effects. The side effects, which can be fatal, include sudden (acute) kidney failure.
There are no views created for this resource yet.
Additional Information
| Field | Value |
|---|---|
| Data last updated | January 16, 2026 |
| Metadata last updated | January 16, 2026 |
| Created | January 16, 2026 |
| Format | HTML |
| License | License not specified |
| Datastore active | False |
| Has views | False |
| Id | 8efd0ffa-fb22-4606-a33a-cb7d01e1fe15 |
| Package id | 36a2e28f-c7d3-46a5-9949-f185075a6e3f |
| Position | 0 |
| State | active |